DRRX
DURECT Corp
Price:  
0.77 
USD
Volume:  
44,926.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRRX EV/EBITDA

-951.4%
Upside

As of 2024-12-12, the EV/EBITDA ratio of DURECT Corp (DRRX) is -1.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRRX's latest enterprise value is 25.31 mil USD. DRRX's TTM EBITDA according to its financial statements is -16.32 mil USD. Dividing these 2 quantities gives us the above DRRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.5x - 9.8x 8.5x
Forward P/E multiples 13.1x - 19.1x 16.3x
Fair Price (6.94) - (5.22) (6.56)
Upside -1000.5% - -776.8% -951.4%
0.77 USD
Stock Price
(6.56) USD
Fair Price

DRRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -1.55
2024-12-10 -1.60
2024-12-09 -1.56
2024-12-06 -1.60
2024-12-05 -1.56
2024-12-04 -1.65
2024-12-03 -1.74
2024-12-02 -1.83
2024-11-29 -1.76
2024-11-27 -1.82
2024-11-26 -1.86
2024-11-25 -1.93
2024-11-22 -2.01
2024-11-21 -1.73
2024-11-20 -1.80
2024-11-19 -1.95
2024-11-18 -1.84
2024-11-15 -2.01
2024-11-14 -2.21
2024-11-13 -2.39
2024-11-12 -2.54
2024-11-11 -2.54
2024-11-08 -2.61
2024-11-07 -2.63
2024-11-06 -2.65
2024-11-05 -2.88
2024-11-04 -2.65
2024-11-01 -2.63
2024-10-31 -2.60
2024-10-30 -2.65
2024-10-29 -2.86
2024-10-28 -2.90
2024-10-25 -2.80
2024-10-24 -2.84
2024-10-23 -2.80
2024-10-22 -2.79
2024-10-21 -2.80
2024-10-18 -2.60
2024-10-17 -2.48
2024-10-16 -2.54
2024-10-15 -2.56
2024-10-14 -2.56
2024-10-11 -2.56
2024-10-10 -2.53
2024-10-09 -2.58
2024-10-08 -2.56
2024-10-07 -2.50
2024-10-04 -2.44
2024-10-03 -2.56
2024-10-02 -2.63